CytoSorbents Corp (CTSO) Stock Price, Quote, News & History

CTSONASDAQ
$0.6800
0.0599.50%
Last update: Apr 20, 8:00 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-12.38M
Investing Cash Flow (TTM)
-415.00K
Financing Cash Flow (TTM)
9.31M
Free Cash Flow (TTM)
-12.87M
Capital Expenditure (TTM)
-491.00K
Net Change in Cash (TTM)
-3.48M

Analyst Trends and Forecast

1
1
Nov 25
1
Dec 25
1
Jan
1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$61.81M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.04
PB Ratio (TTM)
6.60
Earnings Yield % (TTM)
-20.96%
Earnings Yield % (FWD)
-30.64%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.09

Company Debt

Total Debt
$16.67M
LT Debt
$16.67M
LT Debt Issuance (TTM)
$2.48M
LT Debt Repayment (TTM)
$0
Total Cash
$6.25M
Debt to Equity
4.93
Issuance of Debt (TTM)
$2.48M
Repayment of Debt (TTM)
$0

Key Statistics

Open
$0.61
Close
-
Volume / Avg.
9.47K / 88.06K
Day Range
$0.61 - $0.61
52 Wk Range
0.50 - 1.39
Market Cap
$42.71M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
46
Short Interest
3.32%
Days to Cover
15.02

About

Sector
Health Care
Industry
Health Care Equipment & Supplies
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous pol...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CytoSorbents (CTSO) stock?

A

You can purchase shares of CytoSorbents (NASDAQ:CTSO) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for CytoSorbents (CTSO) stock?

A

CytoSorbents has a consensus price target of $5.55.

Q

What is the current price for CytoSorbents (CTSO)?

A

The stock price for CytoSorbents (NASDAQ: CTSO) is $0.68 last updated April 20, 2026 at 8:00 AM EDT.

Q

Does CytoSorbents (CTSO) pay a dividend?

A

There are no upcoming dividends for CytoSorbents.

Q

When is CytoSorbents (NASDAQ:CTSO) reporting earnings?

A

CytoSorbents does not have any upcoming earnings scheduled.

Q

Is CytoSorbents (CTSO) going to split?

A

There is no upcoming split for CytoSorbents.

Q

What sector and industry does CytoSorbents (CTSO) operate in?

A

CytoSorbents is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.